A Prototype Tri-modal Imaging Device for Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Breast Cancer Invasive NosPrimary Invasive Breast Cancer
Interventions
DEVICE

Tri-modal imaging

This tri-modal imaging system was developed in collaboration with Sogang University and is composed of three subsystems: ultrasound, photoacoustic and fluorescence. For this study, the fluorescence subsystem will not be used. The photoacoustic and ultrasound subsystems and data acquisition are controlled by a single workstation. The complete system is Canadian Standards Association (CSA) certified

Trial Locations (1)

M5T 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02794064 - A Prototype Tri-modal Imaging Device for Breast Cancer | Biotech Hunter | Biotech Hunter